• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problem Off-Label Use (1494)
Patient Problems Hemolysis (1886); Cardiac Tamponade (2226); Cardiac Perforation (2513); Valvular Insufficiency/ Regurgitation (4449)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
Related manufacturing reference number : 2135147-2021-00191, 2135147-2021-00193.The article, "transcatheter closure of paravalvular leak: multicenter experience and follow-up", was reviewed.This research article is a retrospective multi-center experience to assess clinical outcomes of consecutive patients with paravalvular leak(pvl) treated with transcatheter techniques.Occlutech paravalvular leak device(occlutech), ampaltzer vascular plug and amplatzer duct occluder(abbott) were associated with the study.There is no allegation of malfunction of the abbott devices.The article concluded that transcatheter closure of pvl can be performed with high technical and clinical success rates and limited complications that lead to significant pvl reduction and functional status improvement.The primary and correspondence author of the article is konstantinos kalogeras, md, phd, 3rd department of cardiology, sotiria hospital, medical school, national & kapodistrian university of athens, athanasiou diakou 23, ilioupoli, 16342, greece with the corresponding email: kalogerask@yahoo.Gr.
 
Manufacturer Narrative
As reported in a research article, perforation, cardiac tamponade, pvl, hemolysis and re-operation occurred following off label implant to mitigate paravalvular leakage.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
MDR Report Key11829097
MDR Text Key250841213
Report Number2135147-2021-00192
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 06/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/17/2021
Initial Date FDA Received05/14/2021
Supplement Dates Manufacturer Received05/14/2021
Supplement Dates FDA Received06/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-